AG
LKFT

Aperio Group’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Aperio Group’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.16M Sell
11,694
-578
-5% -$70.7K ﹤0.01% 1520
2020
Q3 		$1.74M Sell
12,272
-2,820
-19% -$470K 0.01% 1182
2020
Q2 		$2.98M Buy
15,092
+3,149
+26% +$652K 0.01% 928
2020
Q1 		$2.34M Buy
11,943
+5,176
+76% +$1.11M 0.01% 961
2019
Q4 		$1.4M Buy
6,767
+1,614
+31% +$298K 0.01% 1264
2019
Q3 		$787K Buy
5,153
+543
+12% +$89K ﹤0.01% 1523
2019
Q2 		$594K Sell
4,610
-105
-2% -$12.5K ﹤0.01% 1681
2019
Q1 		$555K Sell
4,715
-2,921
-38% -$294K ﹤0.01% 1689
2018
Q4 		$701K Sell
7,636
-1,741
-19% -$177K ﹤0.01% 1498
2018
Q3 		$1.05M Buy
9,377
+1,740
+23% +$184K ﹤0.01% 1376
2018
Q2 		$704K Sell
7,637
-1,663
-18% -$161K ﹤0.01% 1576
2018
Q1 		$928K Buy
9,300
+1,697
+22% +$183K ﹤0.01% 1366
2017
Q4 		$713K Buy
7,603
+3,444
+83% +$326K ﹤0.01% 1516
2017
Q3 		$423K Buy
4,159
+755
+22% +$66K ﹤0.01% 1739
2017
Q2 		$260K Buy
3,404
+1,018
+43% +$85.6K ﹤0.01% 1965
2017
Q1 		$206K Buy
+2,386
New +$172K ﹤0.01% 2023

Other funds holding LKFT

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Aperio Group's LKFT Position: Q4 2020 in Review

Aperio Group reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 4.7% in Q4 2020, selling an estimated $70.7K and leaving 11,694 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1520.

Aperio Group first reported a position in LKFT in Q1 2017 and has held it in 16 quarters since. The position peaked at $2.98M in Q2 2020. 116 funds tracked by Wall St. Rank hold LKFT as of Q4 2020.

  • Aperio Group held 11,694 shares of Lakefront Biotherapeutics American Depositary Shares worth $1.16M as of Q4 2020.
  • Aperio Group sold 578 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2020, an estimated $70.7K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1520 holding.
  • Aperio Group first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2017 and has held it in 16 quarters since.
  • Aperio Group's Lakefront Biotherapeutics American Depositary Shares position peaked at $2.98M in Q2 2020.
  • 116 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.